Under the leadership of Professor Kevin Harrington, we are seeking to appoint a highly motivated Higher Scientific Officer with a strong interest in preclinical in vivo work and cancer biology. The successful candidate will carry out research that preclinically assess direct anti-tumour as well as immune effects of therapies such as radiotherapy / chemoradiotherapy, oncolytic virotherapy and immunotherapies. Part of the project will involve preclinical evaluation of systemically- administered immune activators. The post-holder will provide skilled laboratory assistance using in vivo mouse models, including a wide range of regulated procedures such as subcutaneous, intravenous, intratumoural and intraperitoneal injections. The successful candidate will be expected to carry out technical in vivo work in multiple ongoing research projects in collaboration with other team members and will ensure that study protocols are followed to ensure 3Rs, animal welfare and outstanding science are delivered.
Key Requirements
The successful candidate must have extensive hands-on experience in in vivo mouse model work and hold a current Home Office Personal Licence (PIL), modules (AB&C).
Department/Directorate Information
The Targeted Therapy Team led by Professor Kevin Harrington is part of the Division of Radiotherapy and Imaging at the ICR. We are a translational research team, with interest in ways to activate the immune system to target cancer, for example by using radiotherapy, oncolytic viruses or innate immune agonists. We undertake research to identify mechanisms of action behind successful combination therapy strategies. Areas of activity include thyroid cancer, head and neck cancer and melanoma.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. You may contact Malin Pedersen for further information by emailing [email protected]